Revolution Medicines, Inc. (RVMD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Revolution Medicines, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -13.39x | -12.23x | -7.44x | -7.72x | -9.79x | -24.38x |
| P/B Ratio | 9.28x | 3.24x | 1.78x | 2.80x | 3.04x | 5.55x |
| P/S Ratio | 0.00x | 0.00x | 280.24x | 54.28x | 62.35x | 61.34x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 0.0% | 0.0% | -4207.1% | -730.0% | -639.7% | -257.5% |
| Net Margin | 0.0% | 0.0% | -3768.3% | -703.0% | -636.6% | -251.6% |
| EBITDA Margin | 0.0% | 0.0% | -4126.7% | -702.7% | -611.6% | -237.1% |
| Liquidity | ||||||
| Current Ratio | 7.14x | 14.20x | 13.06x | 10.65x | 9.77x | 9.63x |
| Quick Ratio | 7.14x | 14.20x | 13.06x | 10.65x | 9.77x | 9.63x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.06x | 0.05x | 0.09x | 0.11x | 0.07x |
YoY = year-over-year change. Source: FMP..